Member cost sharing as a percentage of total allowed Rx claims decreased from 2014 to 2019 for both the top quartile and top 5% cohorts, while it increased for the top 1% cohort. However, the percentage of cost sharing increase is not a significant increase as a percentage of total allowed claims